GLP‐1 Receptor Agonists and Clinical Outcomes after Endovascular Treatment of Unruptured Aneurysms in Type 2 Diabetes
Use of GLP-1RAs in patients with unruptured intracranial aneurysms treated via endovascular intervention is associated with improved long-term survival and reduced risks of subarachnoid hemorrhage, hydrocephalus, and poor functional outcomes. These findings suggest a potential therapeutic benefit beyond glycemic control. Prospective studies are needed to validate these results and explore their implications for clinical decision-making in aneurysm treatment.
Authors
- Chih‐Yuan Huang (ORCID: https://orcid.org/0000-0002-0049-7016)
- Hao‐Kuang Wang (ORCID: https://orcid.org/0000-0002-1928-7502)
- Kuan‐Yu Chi (ORCID: https://orcid.org/0000-0003-0763-8157)
- Ming‐Tsung Chuang (ORCID: https://orcid.org/0000-0002-3951-2375)
- Pang‐Shuo Perng (ORCID: https://orcid.org/0000-0003-1102-2144)
- Yuan‐Ting Sun (ORCID: https://orcid.org/0000-0003-2899-1136)
- Yu Chang (ORCID: https://orcid.org/0000-0003-1490-1961)
- Jung‐Shun Lee (ORCID: https://orcid.org/0000-0003-4268-2161)
- Chia‐En Wong (ORCID: https://orcid.org/0000-0003-2434-955X)
- Liang‐Chao Wang (ORCID: https://orcid.org/0000-0003-4341-082X)
Institutions
- Albert Einstein College of Medicine (US)
- E-Da Hospital (TW)
- CHI St. Vincent (US)
- National Cheng Kung University Hospital (TW)
- National Cheng Kung University (TW)
Publication Details
- Journal
- Stroke Vascular and Interventional Neurology
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1161/svin.125.001933
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00